Patients who have been treated for pancreatic cancer could benefit from a newly developed blood test that could identify tiny traces of the disease often missed by scans.

Patients who have been treated for pancreatic cancer could benefit from a newly developed blood test that could identify tiny traces of the disease often missed by scans.

The ultra-sensitive test finds hidden signs and scientists say it could help extend lives